Jürgen Frisch Appointed Chief Medical Officer of European Operations at Clinipace Worldwide

Distinguished Physician and Life Science Executive to Lead European-Based Medical and Regulatory Teams While Providing Expert Guidance and Advisory Services to Clients Worldwide

ZURICH & MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, announced today the appointment of Jürgen Frisch, MD, to Chief Medical Officer of European Operations.

“With Jürgen’s expertise as a researcher and drug developer, clients worldwide will receive the very best guidance and advisory services for their drug development programs”

In this position, Jürgen is responsible for providing leadership and direction to the medical and regulatory service groups within the European Operations at Clinipace Worldwide. Jürgen is based in the Zurich office.

Over his long and distinguished career, Jürgen held several senior medical and management positions at multinational pharmaceutical and biotechnology companies, including Eidetica Biopharma GmbH (a subsidiary of Biogen Idec), immatics biotechnologies GmbH, Intercell AG, Genetics Institute GmbH, HMR Hoechst Marion Roussel GmbH, and Behringwerke AG. Prior to joining Clinipace Worldwide, Jürgen served as a medical reviewer at Swissmedic (Medical Health Authority) in Bern, Switzerland.

Jürgen completed his Medical Doctorate in Internal Medicine at the Johannes Gutenberg University of Mainz, served on the faculty of Medicine in Mainz; and is Board Certified in Internal Medicine.

“With Jürgen’s expertise as a researcher and drug developer, clients worldwide will receive the very best guidance and advisory services for their drug development programs,” said Kurt Pfister, CEO of European Operations at Clinipace Worldwide.

About Clinipace Worldwide

As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified research model to serve the unique needs of emerging and mid-tier biopharmaceutical and medical device firms. Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 600 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Boulder, Overland Park, Zurich, Munich, Tel-Aviv, Sao Paulo, Buenos Aires, Lima, and New Delhi. For more information visit our website at www.clinipace.com.